மருந்து பதிவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biosimilars in China
Tipping the balance: risks and opportunities in biosimilars
Fuelled by changing epidemiology, reimbursement incentives and advancement of the local pharmaceutical industry, the emerging country biosimilar market has been taking an increasingly large share of the global market.
So, what lies in store for multinational pharmaceutical companies (MNCs)? What are the real opportunities and risks in entering these markets and how can the fomer be optimised and the latter minimised?
China, with a burgeoning biosimilar market, has been on top of the strategic agenda for MNCs. However, fierce local competition, lengthy registration processes and unfamiliarity with the country s commercialisation channels have deterred many Western entrants. So, what potential strategies are needed to unlock the opportunities the Chinese biosimilar market presents in the local and global perspective while minimising imminent risks?  ....

Guo Jian , United States , Drug Administration , World Health Organization , Year Plan , State Food , Chinese Revised Provisions , Drug Registrations , Latin America , கூவோ ஜியான் , ஒன்றுபட்டது மாநிலங்களில் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஆண்டு திட்டம் , நிலை உணவு , மருந்து பதிவுகள் , லத்தீன் அமெரிக்கா ,